Abstract
BackgroundImmune checkpoint inhibitors have revolutionized cancer treatment. However, they are associated with a unique spectrum of side effects, called immune-related adverse events (irAEs), which can cause significant morbidity and quickly...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have